虚拟现实自导数字治疗惊恐障碍与广场恐惧症:一项随机对照试验研究方案
本研究为随机对照试验方案,计划纳入30例惊恐障碍、广场恐惧症或伴广场恐惧的惊恐障碍患者,随机分入实验组或对照组。实验组接受6周应用端心理教育、1次虚拟现实暴露疗法(VRET)准备会谈及4周应用端自导VRET;对照组以放松与减压训练替代该次会谈。主要结局为症状严重度,次要结局为随访时缓解状态。
要点
- 方案计划纳入30例惊恐障碍、广场恐惧症或伴广场恐惧的惊恐障碍患者随机分组。
- 实验组接受6周应用端心理教育、1次VRET准备会谈及4周应用端自导VRET。
- 对照组以放松与减压训练替代该次治疗会谈,以控制治疗师会谈的潜在效应。
核心结论
- 本研究旨在探讨包含心理教育与自导VRET的短期治疗应用的效果;若成功,该方法可能成为减轻惊恐障碍、广场恐惧症及伴广场恐惧的惊恐障碍对公共卫生系统负担并促进更快获得治疗的可行且有前景的途径。
研究设计与样本
- 随机对照试验方案,计划纳入30例诊断为惊恐障碍、广场恐惧症或伴广场恐惧的惊恐障碍患者,随机分配至实验组或对照组。
- 两组均在前两次会谈完成基线诊断;实验组后续接受6周应用端心理教育、1次VRET准备会谈及4周应用端自导VRET;对照组以放松与减压训练替代该次治疗师会谈。
- 全部患者在结束会谈后完成治疗后评估(约基线评估后10周),并在结束会谈后6周进行随访评估。
关键数值与推荐
- 主要结局为症状严重度,在基线、中期、治疗后及随访时评估。
- 次要结局为缓解状态,在随访时获取。
- 两组间将比较上述两项指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cognitive behavioral therapy is the first-line treatment for patients with panic disorder (PD) and agoraphobia (AG). Yet, many patients remain untreated due to limited treatment resources. Digital self-guided short-term treatment applications may help to overcome this issue. While some therapeutic applications are already supported by health insurance companies, data on their efficacy is limited. The current study investigates the effect of self-guided digital treatment comprising psychoeducation and virtual reality exposure therapy (VRET). METHODS: Thirty patients diagnosed with PD, AG, or panic disorder with agoraphobia (PDA) will be randomly assigned to either the experimental group (EG) or the control group (CG). Participants of both groups will undergo baseline diagnostics in the first two sessions. The subsequent treatment for the EG consists of a self-guided 6-week phase of application-based psychoeducation, one therapy session preparing for the VRET, and 4 weeks of application-based self-guided VRET. To control for the potential effects of the therapy session with the therapist, the CG will receive relaxation and stress-reduction training instead. All patients will then undergo a closing session which terminates with the post-assessment (~ 10 weeks after baseline assessment) and a follow-up assessment 6 weeks following the closing session. Symptom severity (primary outcome) will be assessed at baseline, interim, post-treatment, and follow-up. Additionally, remission status (secondary outcome) will be obtained at follow-up. Both measures will be compared between the groups. DISCUSSION: The current study aims at providing insights into the efficacy of short-term treatment applications including psychoeducation and self-guided VRET. If successful, this approach might be a feasible and promising way to ease the burden of PD, AG, and PDA on the public health system and contribute to a faster access to treatment. TRIAL REGISTRATION: ISRCTN ISRCTN10661970 . Prospectively registered on 17 January 2022.
引用
- Planert J, Machulska A, Hildebrand AS, et al. Self-guided digital treatment with virtual reality for panic disorder and agoraphobia: a study protocol for a randomized controlled trial. Trials. 2022. PMID: 35597959. doi:10.1186/s13063-022-06366-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。